Miami Neuroscience Institute Neurological Disorders Update

In this course, Diego Torres-Russotto, M.D., discusses the latest, evidence-based treatment of neurological disorders to optimize patient outcomes.  

This course includes topics presented at the 11th annual Miami Neuroscience Symposium.

  • A Clinician's Approach to Tremors
  • Chemodenervation, Dystonia and Spasticity
  • Dementia Management

Commercial Supporter

Baptist Health gratefully acknowledges the educational grants provided by Eisai, Merz, Chiesi, Cerenovus, Ipsen Biopharmaceuticals, and Medtronic. 

Target Audience

Neurologists, Neurosurgeons, Neuroradiologists, Diagnostic Radiologists, Critical Care Physicians, Neurointensivists, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Hospitalists, Critical Care and Neuroscience Nurses, Neurosurgery Nurses, Advanced Practice Nurse Practitioners, Physician Assistants, Clinical Neurophysiology Technicians, Pharmacists, Pharmacy Technicians, Rehabilitation and Pain Management Specialists, Occupational Therapists, as well as other specialists interested in the field of neuroscience.

Learning Objectives

A Clinician’s Approach to Tremors

  • Implement the movement disorders diagnostic process, including the initial patient interview, examination, likely diagnosis and differential diagnosis. 
  • Consider the effect that age and phenomenology have on the movement disorders diagnostic process.  
  • Utilize a tremor algorithm to classify the type of tremor a patient has and select the appropriate therapy.  

Chemodenervation, Dystonia and Spasticity

  • Differentiate between dystonia and spasticity symptoms. 
  • Evaluate the clinical presentation of upper motor neuron syndrome and treat the syndrome-related disturbance with a focus on quality of life. 
  • Involve caregivers in setting post-stroke treatment goals to ensure patient adherence.  
  • Explain advanced treatment options available for dystonia and spasticity. 

Dementia Management

  • Identify risk factors and lifestyle factors that increase risk of dementia.
  • Accurately stage dementia and implement the appropriate treatment, including non-pharmacological interventions.
  • Utilize the DICE – Describe, Investigate, Create, Evaluate – approach to evaluate dementia patients for behavioral and psychological symptoms. 
  • Evaluate patients on anti-amyloid drugs for ARIA-E and ARIA-H through imaging. 
  • Apply inclusion criteria for anti-amyloid drugs and communicate with patients and their families about the complexity and time needed for care. 
Additional information
Bibliography: 
  • Gorodetsky, C., & Fasano, A. (2022). Approach to the treatment of pediatric dystonia. Dystonia, 1, 10287.
  • Yadollahikhales, G., & Rojas, J. C. (2023). Anti-amyloid immunotherapies for Alzheimer’s disease: a 2023 clinical update. Neurotherapeutics, 20(4), 914-931.
  • Pathak, A., Redmond, J. A., Allen, M., & Chou, K. L. (2014). A noninvasive handheld assistive device to accommodate essential tremor: a pilot study. Movement Disorders, 29(6), 838-842.
Course Summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 General certificate of attendance
  • 2.00 Nurse Practitioners
  • 2.00 Florida Board of Nursing
  • 2.00 Florida Board of Occupational Therapy
  • 2.00 Florida Board of Pharmacy
Course opens: 
03/01/2024
Course expires: 
02/28/2027

Faculty

Diego Torres-Russotto, M.D.
Chair of Neurology, Chief of Movement Disorders 
Neurology Residency Program Director 
Miami Neuroscience Institute 
Adjunct Professor, Department of Neurological Sciences 
University of Nebraska Medical Center  
Clinical Professor
Florida International University Herbert Wertheim College of Medicine  
Miami, Florida

Miami Neuroscience Symposium Planning Committee

Kevin Abrams, M.D.   
Chief, Radiology
Medical Director, Neuroradiology and Magnetic Resonance Imaging 
Baptist Hospital 
Clinical Associate Professor of Radiology
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
                                            
Starlie Belnap, Ph.D.  

Clinical Research Supervisor
Miami Neuroscience Institute
Miami, Florida 

Nina Cruz, MSN, APRN, FNP-BC, SCRN   
Coordinator, Stroke Program
Baptist Hospital
Neuroscience Research
Miami Neuroscience Institute
Miami, Florida 

Guilherme Dabus, M.D.    
Co-director, Interventional Neuroradiology
Miami Neuroscience Institute
Medical Director, Fellowship Program in Interventional Neuroradiology and Endovascular Neurosurgery 
Miami Cardiac & Vascular Institute and Miami Neuroscience Institute 
Clinical Professor, Department of Neuroscience
Florida International University Herbert Wertheim College of Medicine 
Miami, Florida    

Felipe De Los Rios La Rosa, M.D., FAHA  
Medical Director, Stroke Program
Miami Neuroscience Institute
Miami, Florida
                
Karel Fuentes, M.D.  

Neurointensivist
Baptist, South Miami, Homestead, Doctors and West Kendall Baptist Hospitals
Medical Director, Neurocritical Care
Miami Neuroscience Institute
Clinical Assistant Professor of Neurology 
Florida International University Herbert Wertheim College of Medicine
Miami, Florida

Italo Linfante, M.D., FAHA  
Director, Interventional Neuroradiology 
Miami Neuroscience Institute 
Clinical Professor of Radiology and Neuroscience 
Florida International University Herbert Wertheim College of Medicine
Miami, Florida 

Michael W. McDermott, M.D., FAANS
Chief Medical Executive
Irma & Kalman Bass Endowed Chair in Clinical Neuroscience
Miami Neuroscience Institute
Chief of the Division of Neuroscience and Professor of Translational Medicine
Florida International University Herbert Wertheim College of Medicine
Miami, Florida

Jamelah Morton, Ph.D., APRN, ACNP-BC, CCRN, CNRN, SCRN  
Neurosurgery Advanced Practice Provider Supervisor
Miami Neuroscience Institute
Miami, Florida 

Regine Narchet
Seizure and Epilepsy Certificate Holder
Epilepsy Coordinator 
Miami Neuroscience Institute
Miami, Florida 

Vitaly Siomin, M.D.   
Neurosurgeon and Medical Director, Brain Tumor Program 
Director, Cerebrovascular Neurosurgery
Co-director, Skull Base Surgery
Miami Neuroscience Institute
Baptist Hospital
Miami, Florida

Justin Sporrer, M.D.   
Director, Functional Neurosurgery
Neurosurgeon 
Miami Neuroscience Institute 
Baptist Health Medical Group
Baptist Health Quality Network
Baptist, Doctors and South Miami Hospitals
Miami, Florida

Ronald Tolchin, D.O.   
Physical Medicine and Rehabilitation
Medical Director, Spine Center
Miami Neuroscience Institute
Baptist Health Medical Group
Baptist Health Quality Network
Baptist Hospital
Miami, Florida

The following directors, planners and reviewers have indicated that they do not have any relevant relationships with ineligible companies* to disclose.
Starlie Belnap, Ph.D.
Nina Cruz, MSN, APRN
Karel Fuentes, M.D.
Jamelah Morton, APRN
Regine Narchet, R.N.
Vitaly Siomin, M.D.
Justin Sporrer, M.D.
Ronald Tolchin, D.O.

Disclosures and Resolution of Conflict of Interest

Kevin Abrams, M.D., is a consultant, speaker and shareholder for Viz.AI, and is a shareholder in Cleerly. 

Guilherme Dabus, M.D., is a consultant for Cerenovus, InNeuroCo, Medtronic, Microvention, Phenox, Penumbra, Route92, Stryker and Viz.Ai; is a member of the speakers’ bureau for Cerenovus, InNeuroCo, Medtronic, Microvention, Penumbra, Phenox, Route92, Stryker and Viz.Ai; is a stockholder in Cleerly, Hyperion, InNeuroCo, Prometheus Laboratories, Inc., RIST, Synchron, Three Rivers Medical, GHIF and Pireaus; receives research support from SUMMIT MAX; and is a committee member for CREST-2 Interventional Management.

Felipe De Los Rios La Rosa, M.D., is on the speakers’ bureau for AstraZeneca, Andexanet alfa and Brilinta.

Italo Linfante, M.D.,** is a consultant for Q’Apel, Cerenovus, Stryker, Medtronic, Penumbra and Prolong Pharmaceuticals. 

Michael McDermott, M.D., is a consultant for Deinde Medical, Stryker, Insightec, ZAP Surgical and Light Helmets. 

Diego Torres-Russotto, M.D., is a consultant for AbbVie, Acorda, Ipsen, Neurocrine, Revance, Sunovion, Teva; is on the speakers’ bureau for AbbVie, Acorda, Ipsen, Neurocrine, Teva; and receives grant support from Ipsen, Merz, Revance.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose. 

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
              
Baptist Health South Florida designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 General certificate of attendance
  • 2.00 Nurse Practitioners
  • 2.00 Florida Board of Nursing
  • 2.00 Florida Board of Occupational Therapy
  • 2.00 Florida Board of Pharmacy
Please login or register for a Baptist Health CME account to take this course.

Required Hardware/Software

PC/Mac Users
PC/Mac Users

This site is supported on the most recent stable releases of the following browsers:

Click Here to Download Google Chrome
Google Chrome
Microsoft Edge
Microsoft Edge
Safari
Safari
Moxilla Firefox
Mozilla Firefox
Mobile Users
Mobile Users

This site is supported on the following mobile devices:

  • Apple iOS mobile devices running iOS 10 or later
  • Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
Technical Support

If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.